News crossing on the Phase 3 results from the trial of Novavax.
- efficacy of 89.3%, in its Phase 3 clinical trial conducted in the United Kingdom (UK)
UK PM Johnson moving the approval process forward in its wake.
UK PM Johnson moving the approval process forward in its wake.
Most Popular
Sponsored
SpaceX stock dips 32%! Is it a buy signal or a warning? Investors eye valuation amid Musk's wealth drop.
SK Hynix & Samsung dive 3% as AI chip mania cools. South Korea's KOSPI slides, warning of a danger zone.
AI stocks face turbulence! Top investors warn of a 30-50% US stock drop, signaling an end to the rally.
Oil jumps 5% as Strait of Hormuz tensions flare. Traders eye geopolitical risk premium.
Samsung & SK Hynix commit $600B+ to AI chip expansion, boosting semiconductor valuations.
Chip giants Samsung, SK Hynix, Micron sued for price-fixing. DRAM prices hit highs amid shortages, raising antitrust red flags.
Apple's $200 price hikes spark antitrust talk. Traders dump shares, fearing regulatory risks and lower valuations.
Sponsored
Must Read